TrialClinical and translational science2021

Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.

John A Kessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.